(Q57122103)

0 references

M Abinun

0 references

T J Flood

0 references

A J Cant

0 references

A R Gennery

Bone Marrow Transplantation

0 references

language of work or name

English

0 references

publication date

April 2005

0 references

published in

0 references

volume

0 references

issue

0 references

page(s)

683-9

0 references

cites work

Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704872

Treatment of the Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome (IPEX) by Allogeneic Bone Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704872

Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704872

CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling tr

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704872

Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704872

Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Bl

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704872

Mixed chimera status of 12 patients with Wiskott-Aldrich syndrome (WAS) after hematopoietic stem cell transplantation: evaluation by flow cytometric analysis of intracellular WAS protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704872

Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704872

Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704872

Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704872

Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704872

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704872

7 January 2021

Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704872

7 January 2021

Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704872

7 January 2021

Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704872

7 January 2021

Correction of persistent thrombocytopenia by a boost of CD133+ selected stem cells in a patient transplanted for Wiskott-Aldrich syndrome 10 years ago

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704872

7 January 2021